New drug shows promise for stubborn back pain

NCT ID NCT04238676

First seen Mar 29, 2026 · Last updated May 15, 2026 · Updated 5 times

Summary

This early-stage study tested an investigational drug called PP353 in 43 adults with chronic low back pain linked to a specific type of spine bone change (Modic 1). The main goals were to check safety and see if the drug reduces pain better than a placebo. Participants had to have moderate to severe pain and were followed for several months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LOW BACK PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CGM Research Trust

    Christchurch, 8083, New Zealand

  • Gildhøj Privathospital København

    Copenhagen, 2605 Brøndby, Denmark

  • Hospital Universitario LA PAZ

    Madrid, Spain

  • Hospital Vithas Granada

    Granada, Spain

  • Leeds General Infirmary

    Leeds, LS1 3EX, United Kingdom

  • Oxford University Hospitals NHS Foundation Trust

    Oxford, Oxford, OX3 9DU, United Kingdom

  • Royal Preston Hospital

    Preston, Lancashire, PR2 9HT, United Kingdom

  • University Hospital Coventry & Warwickshire

    Coventry, CV2 2DX, United Kingdom

  • University Hospital Of Wales

    Cardiff, Wales, CF14 4XW, United Kingdom

  • University Hospital Southampton Nhs Foundation Trust

    Southampton, SO16 6YD, United Kingdom

Conditions

Explore the condition pages connected to this study.